Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07412548

Autogenic Relaxation and Murottal Therapy in Hemodialysis Patients

This quasi-experimental study aims to evaluate the effect of combined autogenic relaxation and Surah Ar-Rahman murottal therapy on anxiety, sleep quality, and hemodynamic parameters in hemodialysis patients. A pretest-posttest control group design will be used involving 76 participants undergoing routine hemodialysis. Participants will be assigned to an intervention group receiving structured autogenic relaxation followed by murottal therapy and a control group receiving standard care with music listening. Anxiety, sleep quality, and hemodynamic parameters will be measured at baseline and after a 6-week intervention period. The findings are expected to support the use of non-pharmacological and spiritual-based interventions in improving psychological and physiological outcomes in hemodialysis patients.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Chronic Kidney Disease Stage V Anxiety Disorders Chronic Disease Disease Attributes Dyssomnias End-stage Renal Disease Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Hemodialysis Kidney Diseases Kidney Failure, Chronic Male Urogenital Diseases Mental Disorders Nervous System Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Renal Insufficiency Renal Insufficiency, Chronic Sleep Disorders, Intrinsic Sleep Initiation and Maintenance Disorders Sleep Wake Disorders Urogenital Diseases Urologic Diseases

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

This study applies a quasi-experimental pretest-posttest control group design. The intervention group receives structured autogenic relaxation followed by Surah Ar-Rahman murottal therapy for 10-15 minutes per session, twice weekly for six weeks. The control group receives standard hemodialysis care with music listening. Anxiety, sleep quality, and hemodynamic parameters are assessed before and after the intervention.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients diagnosed with stage V chronic kidney disease.
  • Undergoing scheduled hemodialysis at least twice a week for 6 weeks.
  • Outpatients and aged 18-65 years.
  • Muslim.
  • Cooperative and able to communicate verbally.
  • Willing to be a respondent by signing an informed consent form.

Exclusion criteria

  • Having a severe heart condition or an unstable critical condition.
  • Having a severe psychiatric disorder (schizophrenia, major depression).
  • Having a cognitive, hearing, or speech disorder that impedes communication.
  • Taking antidepressants, anxiolytics, or neuroleptics that may affect psychological measurement results.

Treatment and study plan

Autogenic Relaxation and Surah Ar-Rahman Murottal Therapy

Behavioral

A structured non-pharmacological intervention consisting of autogenic relaxation techniques including breathing regulation, muscle relaxation, and self-suggestion, followed by listening to Surah Ar-Rahman murottal recitation using earphones. Each session lasts 10-15 minutes and is conducted twice weekly for six weeks during routine hemodialysis.

listening to dangdut music

Other

listening to dangdut music for 10 to 15 minutes within 6 weeks

Primary outcomes

  1. Anxiety

    Time frame: Baseline and after completion of the 6-week intervention

    Change in anxiety level measured using the Zung Self-Rating Anxiety Scale (ZSAS; range 20-80), where higher scores indicate greater anxiety, from baseline to after completion of the 6-week intervention.

  2. Sleep Quality

    Time frame: Baseline and after completion of the 6-week intervention.

    Change in sleep quality measured using the Pittsburgh Sleep Quality Index (PSQI; range 0-21), where higher scores indicate poorer sleep quality, from baseline to after completion of the 6-week intervention.

  3. Blood Presure

    Time frame: Baseline and after completion of the 6-week intervention

    Change in systolic blood pressure (mmHg), measured using a calibrated digital sphygmomanometer, from baseline to after completion of the 6-week intervention.

  4. Heart Rate

    Time frame: Baseline and after completion of the 6-week intervention

    Change in heart rate (beats per minute, bpm), measured using a digital bedside patient monitor, from baseline to after completion of the 6-week intervention.

Study contacts

Contact information is provided by the study sponsor or research team.

Dyan Kurniasari, S.Kep.,Ns

CONTACT

[email protected]

+628122593391

Sponsors and collaborators

Lead sponsor

Universitas Muhammadiyah Surakarta

Other

Registry information

Official study title

The Effectiveness of Autogenic Relaxation and Surah Ar-Rahman Murottal Therapy on Anxiety, Sleep Quality, and Hemodynamic Parameters in Hemodialysis Patients

Acronym: AR-MHD

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Feb 17, 2026
Registry last updated
Feb 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.